Background: Livestock-associated (LA)-MRSA of CC398 lineage is related to the pig environment, although it also colonizes/infects humans. Tetracycline resistance (TETR) is a phenotypic marker of LA-MRSA-CC398.
Objectives: To determine the prevalence and changing epidemiology of LA-MRSA-CC398 in seven Spanish hospitals (H1-H7) located in areas with different pig farming densities (PFDs) (extremely high, very high, medium, and very low: EH/VH/M/VL), and to identify other non-CC398-LA-MRSA clones.
Methods: MRSA-TETR isolates (n = 165) obtained from hospitals H1-H7 over 6 months in 2023 were characterized with respect to genetic lineages/antimicrobial resistance and virulence/immune evasion cluster of CC398 and non-CC398. Results were compared with a previous multicentre study from 2016.
Results: We identified 86/165 MRSA-TETR isolates (52.1%) as being MRSA-CC398. A significant difference in MRSA-CC398/MRSA prevalence was detected between hospitals located in EH-PFD areas (H1 and H2, > 25%) and the one in a VL-PFD area (H7, 0%). Prevalences in the range 6.4%-12.2% were found in hospitals in M- and VH-PFD areas (H3-H6). Fourteen spa-types were identified among MRSA-CC398 isolates, with t011/t034 predominating (68.3%), followed by t1451/t1255 (13%). All but two MRSA-CC398 isolates were scn-negative (human adaptation marker). Among the 79 non-CC398-MRSA-TETR isolates, CC5, CC1 and CC8 predominated (45.6%, scn-negative). The prevalences of the scn gene among non-CC398-MRSA-TETR isolates in hospitals of EH-, VH-, M- and VL-PFD areas were 77.8%, 50%, 18.75% and 0%, respectively (significant correlation, P < 0.05). This study shows that MRSA-CC398 isolates are prevalent in hospitals located in EH-PFD areas but absent in the hospital of the VL-PFD area. Moreover, an increase in both PFD and prevalence of MRSA-CC398/MRSA in hospitals H3-H6 was observed in the 2023 study compared with the 2016 study.
Conclusions: A significant increase and more genetic diversity of predominant lineages of CC398-MRSA-TETR were observed in hospitals located in M- to VH-PFD areas.
© The Author(s) 2025. Published by Oxford University Press on behalf of British Society for Antimicrobial Chemotherapy. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.